BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Belevych AE, Sansom SE, Terentyeva R, Ho HT, Nishijima Y, Martin MM, Jindal HK, Rochira JA, Kunitomo Y, Abdellatif M. MicroRNA-1 and -133 increase arrhythmogenesis in heart failure by dissociating phosphatase activity from RyR2 complex. PLoS One. 2011;6:e28324. [PMID: 22163007 DOI: 10.1371/journal.pone.0028324] [Cited by in Crossref: 108] [Cited by in F6Publishing: 102] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Ai X, Yan J, Pogwizd SM. Serine-threonine protein phosphatase regulation of Cx43 dephosphorylation in arrhythmogenic disorders. Cell Signal 2021;86:110070. [PMID: 34217833 DOI: 10.1016/j.cellsig.2021.110070] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Long G, Wang F, Duan Q, Chen F, Yang S, Gong W, Wang Y, Chen C, Wang DW. Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction. Int J Biol Sci. 2012;8:811-818. [PMID: 22719221 DOI: 10.7150/ijbs.4439] [Cited by in Crossref: 113] [Cited by in F6Publishing: 113] [Article Influence: 11.3] [Reference Citation Analysis]
3 Belevych AE, Ho HT, Terentyeva R, Bonilla IM, Terentyev D, Carnes CA, Gyorke S, Billman GE. Dietary omega-3 fatty acids promote arrhythmogenic remodeling of cellular Ca2+ handling in a postinfarction model of sudden cardiac death. PLoS One 2013;8:e78414. [PMID: 24205228 DOI: 10.1371/journal.pone.0078414] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gao H, Zhang L, Wang Z, Yan K, Zhao L, Xiao W. Research Progress on Transorgan Regulation of the Cardiovascular and Motor System through Cardiogenic Exosomes. IJMS 2022;23:5765. [DOI: 10.3390/ijms23105765] [Reference Citation Analysis]
5 Li X, Wang B, Cui H, Du Y, Song Y, Yang L, Zhang Q, Sun F, Luo D, Xu C, Chu W, Lu Y, Yang B. let-7e replacement yields potent anti-arrhythmic efficacy via targeting beta 1-adrenergic receptor in rat heart. J Cell Mol Med 2014;18:1334-43. [PMID: 24758696 DOI: 10.1111/jcmm.12288] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
6 Devaux Y, Vausort M, McCann GP, Kelly D, Collignon O, Ng LL, Wagner DR, Squire IB. A panel of 4 microRNAs facilitates the prediction of left ventricular contractility after acute myocardial infarction. PLoS One. 2013;8:e70644. [PMID: 23967079 DOI: 10.1371/journal.pone.0070644] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 7.2] [Reference Citation Analysis]
7 Li Y, Huo C, Pan T, Li L, Jin X, Lin X, Chen J, Zhang J, Guo Z, Xu J, Li X. Systematic review regulatory principles of non-coding RNAs in cardiovascular diseases. Brief Bioinform 2019;20:66-76. [PMID: 28968629 DOI: 10.1093/bib/bbx095] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
8 Weber S, Meyer-Roxlau S, Wagner M, Dobrev D, El-Armouche A. Counteracting Protein Kinase Activity in the Heart: The Multiple Roles of Protein Phosphatases. Front Pharmacol 2015;6:270. [PMID: 26617522 DOI: 10.3389/fphar.2015.00270] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
9 Boštjančič E, Zidar N, Glavač D. MicroRNAs and cardiac sarcoplasmic reticulum calcium ATPase-2 in human myocardial infarction: expression and bioinformatic analysis. BMC Genomics 2012;13:552. [PMID: 23066896 DOI: 10.1186/1471-2164-13-552] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
10 Kalozoumi G, Yacoub M, Sanoudou D. MicroRNAs in heart failure: Small molecules with major impact. Glob Cardiol Sci Pract. 2014;2014:79-102. [PMID: 25419522 DOI: 10.5339/gcsp.2014.30] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
11 Chen P, Wang L, Fan X, Ning X, Yu B, Ou C, Chen M. Targeted delivery of extracellular vesicles in heart injury. Theranostics 2021;11:2263-77. [PMID: 33500724 DOI: 10.7150/thno.51571] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 15.0] [Reference Citation Analysis]
12 Clauss S, Sinner MF, Kääb S, Wakili R. The Role of MicroRNAs in Antiarrhythmic Therapy for Atrial Fibrillation. Arrhythm Electrophysiol Rev 2015;4:146-55. [PMID: 26835117 DOI: 10.15420/aer.2015.4.3.146] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
13 Jayawardena E, Medzikovic L, Ruffenach G, Eghbali M. Role of miRNA-1 and miRNA-21 in Acute Myocardial Ischemia-Reperfusion Injury and Their Potential as Therapeutic Strategy. Int J Mol Sci 2022;23:1512. [PMID: 35163436 DOI: 10.3390/ijms23031512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Quattrocelli M, Crippa S, Montecchiani C, Camps J, Cornaglia AI, Boldrin L, Morgan J, Calligaro A, Casasco A, Orlacchio A, Gijsbers R, D'Hooge J, Toelen J, Janssens S, Sampaolesi M. Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice. J Am Heart Assoc 2013;2:e000284. [PMID: 23963759 DOI: 10.1161/JAHA.113.000284] [Cited by in Crossref: 40] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
15 Liao C, Gui Y, Guo Y, Xu D. The regulatory function of microRNA-1 in arrhythmias. Mol Biosyst 2016;12:328-33. [PMID: 26671473 DOI: 10.1039/c5mb00806a] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
16 Hamilton S, Terentyev D. Proarrhythmic Remodeling of Calcium Homeostasis in Cardiac Disease; Implications for Diabetes and Obesity. Front Physiol 2018;9:1517. [PMID: 30425651 DOI: 10.3389/fphys.2018.01517] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Gui Y, Li D, Chen J, Wang Y, Hu J, Liao C, Deng L, Xiang Q, Yang T, Du X, Zhang S, Xu D. Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction. Lipids Health Dis 2018;17:129. [PMID: 29843720 DOI: 10.1186/s12944-018-0780-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
18 Hamilton S, Veress R, Belevych A, Terentyev D. The role of calcium homeostasis remodeling in inherited cardiac arrhythmia syndromes. Pflugers Arch 2021;473:377-87. [PMID: 33404893 DOI: 10.1007/s00424-020-02505-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Ibrahim A, Marbán E. Exosomes: Fundamental Biology and Roles in Cardiovascular Physiology. Annu Rev Physiol 2016;78:67-83. [PMID: 26667071 DOI: 10.1146/annurev-physiol-021115-104929] [Cited by in Crossref: 115] [Cited by in F6Publishing: 120] [Article Influence: 16.4] [Reference Citation Analysis]
20 Razavi-azarkhiavi K, Jaafari MR, Abnous K, Razavi BM, Jafarian AH, Hassani FV, Shirani K, Karimi G. The Cardiotoxic Mechanism of Doxorubicin (DOX) and Pegylated Liposomal DOX in Mice Bearing C-26 Colon Carcinoma: a Study Focused on microRNA Role for Toxicity Assessment of New Formulations. Pharm Res 2017;34:1849-56. [DOI: 10.1007/s11095-017-2194-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
21 Alajbegovic A, Turczyńska KM, Hien TT, Cidad P, Swärd K, Hellstrand P, Della Corte A, Forte A, Albinsson S. Regulation of microRNA expression in vascular smooth muscle by MRTF-A and actin polymerization. Biochim Biophys Acta Mol Cell Res 2017;1864:1088-98. [PMID: 27939432 DOI: 10.1016/j.bbamcr.2016.12.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
22 Lozano-Velasco E, Hernández-Torres F, Daimi H, Serra SA, Herraiz A, Hove-Madsen L, Aránega A, Franco D. Pitx2 impairs calcium handling in a dose-dependent manner by modulating Wnt signalling. Cardiovasc Res 2016;109:55-66. [PMID: 26243430 DOI: 10.1093/cvr/cvv207] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 6.1] [Reference Citation Analysis]
23 Qin R, Murakoshi N, Xu D, Tajiri K, Feng D, Stujanna EN, Yonebayashi S, Nakagawa Y, Shimano H, Nogami A, Koike A, Aonuma K, Ieda M. Exercise training reduces ventricular arrhythmias through restoring calcium handling and sympathetic tone in myocardial infarction mice. Physiol Rep 2019;7:e13972. [PMID: 30806037 DOI: 10.14814/phy2.13972] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
24 Vatta M, Chen PS. CaMKII and ryanodine receptor as new antiarrhythmic targets. Heart Rhythm 2012;9:2042-3. [PMID: 22982962 DOI: 10.1016/j.hrthm.2012.09.011] [Reference Citation Analysis]
25 Tian M, Zhou Y, Jia H, Zhu X, Cui Y. The Clinical Significance of Changes in the Expression Levels of MicroRNA-1 and Inflammatory Factors in the Peripheral Blood of Children with Acute-Stage Asthma. Biomed Res Int 2018;2018:7632487. [PMID: 30046607 DOI: 10.1155/2018/7632487] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
26 Liu Q, Zhao X, Peng R, Wang M, Zhao W, Gui Y, Liao C, Xu D. Soluble epoxide hydrolase inhibitors might prevent ischemic arrhythmias via microRNA-1 repression in primary neonatal mouse ventricular myocytes. Mol BioSyst 2017;13:556-64. [DOI: 10.1039/c6mb00824k] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
27 Kura B, Kalocayova B, Devaux Y, Bartekova M. Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and Cardioprotection. Int J Mol Sci 2020;21:E700. [PMID: 31973111 DOI: 10.3390/ijms21030700] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
28 Colpaert RMW, Calore M. MicroRNAs in Cardiac Diseases. Cells 2019;8:E737. [PMID: 31323768 DOI: 10.3390/cells8070737] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 18.0] [Reference Citation Analysis]
29 Wang H, Cai J. The role of microRNAs in heart failure. Biochim Biophys Acta Mol Basis Dis 2017;1863:2019-30. [PMID: 27916680 DOI: 10.1016/j.bbadis.2016.11.034] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
30 Huang CL. Murine Electrophysiological Models of Cardiac Arrhythmogenesis. Physiol Rev. 2017;97:283-409. [PMID: 27974512 DOI: 10.1152/physrev.00007.2016] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 11.0] [Reference Citation Analysis]
31 Kuzmin VS, Ivanova AD, Filatova TS, Pustovit KB, Kobylina AA, Atkinson AJ, Petkova M, Voronkov YI, Abramochkin DV, Dobrzynski H. Micro-RNA 133a-3p induces repolarization abnormalities in atrial myocardium and modulates ventricular electrophysiology affecting ICa,L and Ito currents. Eur J Pharmacol 2021;908:174369. [PMID: 34310913 DOI: 10.1016/j.ejphar.2021.174369] [Reference Citation Analysis]
32 Mirzadeh Azad F, Arabian M, Maleki M, Malakootian M. Small Molecules with Big Impacts on Cardiovascular Diseases. Biochem Genet 2020;58:359-83. [PMID: 31997044 DOI: 10.1007/s10528-020-09948-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
33 Salamon I, Biagini E, Kunderfranco P, Roncarati R, Ferracin M, Taglieri N, Nardi E, Laprovitera N, Tomasi L, Santostefano M, Ditaranto R, Vitale G, Cavarretta E, Pisani A, Riccio E, Aiello V, Capelli I, La Manna G, Galiè N, Spinelli L, Condorelli G. Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson-Fabry disease. Cell Death Dis 2021;12:1150. [PMID: 34897278 DOI: 10.1038/s41419-021-04438-5] [Reference Citation Analysis]
34 Lee S, Choi E, Kim SM, Hwang KC. MicroRNAs as mediators of cardiovascular disease: Targets to be manipulated. World J Biol Chem 2015; 6(2): 34-38 [PMID: 26009702 DOI: 10.4331/wjbc.v6.i2.34] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
35 Liu Y, Liang Y, Zhang JF, Fu WM. MicroRNA-133 mediates cardiac diseases: Mechanisms and clinical implications. Exp Cell Res 2017;354:65-70. [PMID: 28322824 DOI: 10.1016/j.yexcr.2017.03.037] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
36 Yan H, Huang J, Chen Y, Yao J, Cen W, Li J, Jiang Y, Chen G, Li S. Role of miR-1 expression in clear cell renal cell carcinoma (ccRCC): A bioinformatics study based on GEO, ArrayExpress microarrays and TCGA database. Pathology - Research and Practice 2018;214:195-206. [DOI: 10.1016/j.prp.2017.11.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
37 Chistiakov DA, Orekhov AN, Bobryshev YV. Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction). J Mol Cell Cardiol 2016;94:107-21. [PMID: 27056419 DOI: 10.1016/j.yjmcc.2016.03.015] [Cited by in Crossref: 116] [Cited by in F6Publishing: 113] [Article Influence: 19.3] [Reference Citation Analysis]
38 Terentyev D, Hamilton S. Regulation of sarcoplasmic reticulum Ca2+ release by serine-threonine phosphatases in the heart. J Mol Cell Cardiol 2016;101:156-64. [PMID: 27585747 DOI: 10.1016/j.yjmcc.2016.08.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
39 Harada M, Luo X, Murohara T, Yang B, Dobrev D, Nattel S. MicroRNA Regulation and Cardiac Calcium Signaling: Role in Cardiac Disease and Therapeutic Potential. Circ Res 2014;114:689-705. [DOI: 10.1161/circresaha.114.301798] [Cited by in Crossref: 87] [Cited by in F6Publishing: 48] [Article Influence: 10.9] [Reference Citation Analysis]
40 Feng Y, Niu LL, Wei W, Zhang WY, Li XY, Cao JH, Zhao SH. A feedback circuit between miR-133 and the ERK1/2 pathway involving an exquisite mechanism for regulating myoblast proliferation and differentiation. Cell Death Dis. 2013;4:e934. [PMID: 24287695 DOI: 10.1038/cddis.2013.462] [Cited by in Crossref: 91] [Cited by in F6Publishing: 88] [Article Influence: 10.1] [Reference Citation Analysis]
41 Celik S, Karbalaei-Sadegh M, Rådegran G, Smith JG, Gidlöf O. Functional Screening Identifies MicroRNA Regulators of Corin Activity and Atrial Natriuretic Peptide Biogenesis. Mol Cell Biol 2019;39:e00271-19. [PMID: 31548261 DOI: 10.1128/MCB.00271-19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
42 Mitchelson KR, Qin WY. Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease. World J Biol Chem 2015; 6(3): 162-208 [PMID: 26322174 DOI: 10.4331/wjbc.v6.i3.162] [Cited by in CrossRef: 85] [Cited by in F6Publishing: 77] [Article Influence: 12.1] [Reference Citation Analysis]
43 Bonet F, Hernandez-Torres F, Esteban FJ, Aranega A, Franco D. Comparative Analyses of MicroRNA Microarrays during Cardiogenesis: Functional Perspectives. Microarrays (Basel) 2013;2:81-96. [PMID: 27605182 DOI: 10.3390/microarrays2020081] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
44 Besser J, Malan D, Wystub K, Bachmann A, Wietelmann A, Sasse P, Fleischmann BK, Braun T, Boettger T. MiRNA-1/133a clusters regulate adrenergic control of cardiac repolarization. PLoS One 2014;9:e113449. [PMID: 25415383 DOI: 10.1371/journal.pone.0113449] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
45 Hamilton S, Terentyev D. Proarrhythmic Remodeling of Calcium Homeostasis in Cardiac Disease; Implications for Diabetes and Obesity. Front Physiol 2018;9:1517. [PMID: 30425651 DOI: 10.3389/fphys.2018.01517] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
46 Osbourne A, Calway T, Broman M, McSharry S, Earley J, Kim GH. Downregulation of connexin43 by microRNA-130a in cardiomyocytes results in cardiac arrhythmias. J Mol Cell Cardiol 2014;74:53-63. [PMID: 24819345 DOI: 10.1016/j.yjmcc.2014.04.024] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
47 Boštjančič E, Brandner T, Zidar N, Glavač D, Štajer D. Down-regulation of miR-133a/b in patients with myocardial infarction correlates with the presence of ventricular fibrillation. Biomed Pharmacother 2018;99:65-71. [PMID: 29324314 DOI: 10.1016/j.biopha.2018.01.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
48 Curcio A, Torella D, Iaconetti C, Pasceri E, Sabatino J, Sorrentino S, Giampà S, Micieli M, Polimeni A, Henning BJ. MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts. PLoS One. 2013;8:e70158. [PMID: 23922949 DOI: 10.1371/journal.pone.0070158] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 6.1] [Reference Citation Analysis]
49 Lee S, Choi E, Cha MJ, Hwang KC. Looking into a conceptual framework of ROS-miRNA-atrial fibrillation. Int J Mol Sci 2014;15:21754-76. [PMID: 25431922 DOI: 10.3390/ijms151221754] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
50 Choi E, Cha MJ, Hwang KC. Roles of Calcium Regulating MicroRNAs in Cardiac Ischemia-Reperfusion Injury. Cells 2014;3:899-913. [PMID: 25216032 DOI: 10.3390/cells3030899] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
51 Duygu B, Poels EM, da Costa Martins PA. Genetics and epigenetics of arrhythmia and heart failure. Front Genet. 2013;4:219. [PMID: 24198825 DOI: 10.3389/fgene.2013.00219] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
52 Mericskay M. [MicroRNAs: what cardiologists should know about them?]. Presse Med 2015;44:761-71. [PMID: 26163829 DOI: 10.1016/j.lpm.2015.05.005] [Reference Citation Analysis]
53 Tanaka Y, Tsuda S, Kunikata H, Sato J, Kokubun T, Yasuda M, Nishiguchi KM, Inada T, Nakazawa T. Profiles of extracellular miRNAs in the aqueous humor of glaucoma patients assessed with a microarray system. Sci Rep 2014;4:5089. [PMID: 24867291 DOI: 10.1038/srep05089] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 6.3] [Reference Citation Analysis]
54 Sun Z, Xu H. Ryanodine Receptors for Drugs and Insecticides: An Overview. MRMC 2018;19:22-33. [DOI: 10.2174/1389557518666180330112908] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
55 Qin H, Chen GX, Liang MY, Rong J, Yao JP, Liu H, Wu ZK. The altered expression profile of microRNAs in cardiopulmonary bypass canine models and the effects of mir-499 on myocardial ischemic reperfusion injury. J Transl Med. 2013;11:154. [PMID: 23800236 DOI: 10.1186/1479-5876-11-154] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
56 Dees E, Miller PM, Moynihan KL, Pooley RD, Hunt RP, Galindo CL, Rottman JN, Bader DM. Cardiac-specific deletion of the microtubule-binding protein CENP-F causes dilated cardiomyopathy. Dis Model Mech 2012;5:468-80. [PMID: 22563055 DOI: 10.1242/dmm.008680] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
57 Lui P, Jin D, Stevenson NJ. MicroRNA: master controllers of intracellular signaling pathways. Cell Mol Life Sci 2015;72:3531-42. [DOI: 10.1007/s00018-015-1940-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 5.4] [Reference Citation Analysis]
58 Ho HT, Belevych AE, Liu B, Bonilla IM, Radwański PB, Kubasov IV, Valdivia HH, Schober K, Carnes CA, Györke S. Muscarinic Stimulation Facilitates Sarcoplasmic Reticulum Ca Release by Modulating Ryanodine Receptor 2 Phosphorylation Through Protein Kinase G and Ca/Calmodulin-Dependent Protein Kinase II. Hypertension 2016;68:1171-8. [PMID: 27647848 DOI: 10.1161/HYPERTENSIONAHA.116.07666] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
59 Kim GH. MicroRNA regulation of cardiac conduction and arrhythmias. Transl Res 2013;161:381-92. [PMID: 23274306 DOI: 10.1016/j.trsl.2012.12.004] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 7.3] [Reference Citation Analysis]
60 Dunmire JJ, Lagouros E, Bouhenni RA, Jones M, Edward DP. MicroRNA in aqueous humor from patients with cataract. Exp Eye Res 2013;108:68-71. [PMID: 23146683 DOI: 10.1016/j.exer.2012.10.016] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
61 Song MA, Paradis AN, Gay MS, Shin J, Zhang L. Differential expression of microRNAs in ischemic heart disease. Drug Discov Today 2015;20:223-35. [PMID: 25461956 DOI: 10.1016/j.drudis.2014.10.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
62 Vilches J, Pulido A, Hernández-torres F, Franco D, Aránega A. miR-27b and miR-23b Modulate Cardiomyocyte Differentiation from Mouse Embryonic Stem Cells. JCDD 2014;1:41-51. [DOI: 10.3390/jcdd1010041] [Reference Citation Analysis]
63 Liu C, Wang Q, Zong D, Pei S, Yan Y, Yan M, Sun L, Hao Y, Mao M, Xing W, Ren H, Ai J. Knockdown of microRNA-195 contributes to protein phosphatase-2A inactivation in rats with chronic brain hypoperfusion. Neurobiology of Aging 2016;45:76-87. [DOI: 10.1016/j.neurobiolaging.2016.05.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
64 Terentyev D, Rees CM, Li W, Cooper LL, Jindal HK, Peng X, Lu Y, Terentyeva R, Odening KE, Daley J, Bist K, Choi BR, Karma A, Koren G. Hyperphosphorylation of RyRs underlies triggered activity in transgenic rabbit model of LQT2 syndrome. Circ Res 2014;115:919-28. [PMID: 25249569 DOI: 10.1161/CIRCRESAHA.115.305146] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 5.1] [Reference Citation Analysis]
65 Zarà M, Amadio P, Campodonico J, Sandrini L, Barbieri SS. Exosomes in Cardiovascular Diseases. Diagnostics (Basel) 2020;10:E943. [PMID: 33198302 DOI: 10.3390/diagnostics10110943] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
66 Zhu W, Wang C, Hu J, Wan R, Yu J, Xie J, Ma J, Guo L, Ge J, Qiu Y, Chen L, Liu H, Yan X, Liu X, Ye J, He W, Shen Y, Wang C, Mohler PJ, Hong K. Ankyrin-B Q1283H Variant Linked to Arrhythmias Via Loss of Local Protein Phosphatase 2A Activity Causes Ryanodine Receptor Hyperphosphorylation. Circulation 2018;138:2682-97. [PMID: 30571258 DOI: 10.1161/CIRCULATIONAHA.118.034541] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
67 Lew JK, Pearson JT, Schwenke DO, Katare R. Exercise mediated protection of diabetic heart through modulation of microRNA mediated molecular pathways. Cardiovasc Diabetol. 2017;16:10. [PMID: 28086863 DOI: 10.1186/s12933-016-0484-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
68 Zhang X, Schulze PC. MicroRNAs in heart failure: Non-coding regulators of metabolic function. Biochim Biophys Acta 2016;1862:2276-87. [PMID: 27544699 DOI: 10.1016/j.bbadis.2016.08.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
69 Han C, Yu Z, Duan Z, Kan Q. Role of microRNA-1 in human cancer and its therapeutic potentials. Biomed Res Int. 2014;2014:428371. [PMID: 24949449 DOI: 10.1155/2014/428371] [Cited by in Crossref: 37] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
70 Terentyev D, Rochira JA, Terentyeva R, Roder K, Koren G, Li W. Sarcoplasmic reticulum Ca²⁺ release is both necessary and sufficient for SK channel activation in ventricular myocytes. Am J Physiol Heart Circ Physiol 2014;306:H738-46. [PMID: 24381116 DOI: 10.1152/ajpheart.00621.2013] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
71 Heijman J, Dewenter M, El-Armouche A, Dobrev D. Function and regulation of serine/threonine phosphatases in the healthy and diseased heart. J Mol Cell Cardiol 2013;64:90-8. [PMID: 24051368 DOI: 10.1016/j.yjmcc.2013.09.006] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 8.7] [Reference Citation Analysis]
72 Wei XJ, Han M, Yang FY, Wei GC, Liang ZG, Yao H, Ji CW, Xie RS, Gong CL, Tian Y. Biological significance of miR-126 expression in atrial fibrillation and heart failure. Braz J Med Biol Res 2015;48:983-9. [PMID: 26313139 DOI: 10.1590/1414-431X20154590] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
73 Ruvolo PP. The Interplay between PP2A and microRNAs in Leukemia. Front Oncol 2015;5:43. [PMID: 25750899 DOI: 10.3389/fonc.2015.00043] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
74 Yang X, Wang Q, Zeng Z, Zhang Q, Liu F, Chang H, Li C, Wang W, Wang Y. The Protective Effect of Qishen Granule on Heart Failure after Myocardial Infarction through Regulation of Calcium Homeostasis. Evid Based Complement Alternat Med 2020;2020:1868974. [PMID: 33149749 DOI: 10.1155/2020/1868974] [Reference Citation Analysis]
75 Vogel B, Keller A, Frese KS, Leidinger P, Sedaghat-Hamedani F, Kayvanpour E, Kloos W, Backe C, Thanaraj A, Brefort T. Multivariate miRNA signatures as biomarkers for non-ischaemic systolic heart failure. Eur Heart J. 2013;34:2812-2822. [PMID: 23864135 DOI: 10.1093/eurheartj/eht256] [Cited by in Crossref: 69] [Cited by in F6Publishing: 67] [Article Influence: 7.7] [Reference Citation Analysis]
76 Ravelli F, Masè M. MicroRNAs: New contributors to mechano-electric coupling and atrial fibrillation. Prog Biophys Mol Biol 2021;159:146-56. [PMID: 33011190 DOI: 10.1016/j.pbiomolbio.2020.09.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Kushnir A, Wajsberg B, Marks AR. Ryanodine receptor dysfunction in human disorders. Biochim Biophys Acta Mol Cell Res 2018;1865:1687-97. [PMID: 30040966 DOI: 10.1016/j.bbamcr.2018.07.011] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 10.5] [Reference Citation Analysis]
78 Guo M, Luo J, Zhao J, Shang D, Lv Q, Zang P. Combined Use of Circulating miR-133a and NT-proBNP Improves Heart Failure Diagnostic Accuracy in Elderly Patients. Med Sci Monit 2018;24:8840-8. [PMID: 30523241 DOI: 10.12659/MSM.911632] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
79 Greer JB, Magnuson JT, McGruer V, Qian L, Dasgupta S, Volz DC, Schlenk D. miR133b Microinjection during Early Development Targets Transcripts of Cardiomyocyte Ion Channels and Induces Oil-like Cardiotoxicity in Zebrafish (Danio rerio) Embryos. Chem Res Toxicol 2021;34:2209-15. [PMID: 34558284 DOI: 10.1021/acs.chemrestox.1c00238] [Reference Citation Analysis]
80 Cooper LL, Li W, Lu Y, Centracchio J, Terentyeva R, Koren G, Terentyev D. Redox modification of ryanodine receptors by mitochondria-derived reactive oxygen species contributes to aberrant Ca2+ handling in ageing rabbit hearts. J Physiol 2013;591:5895-911. [PMID: 24042501 DOI: 10.1113/jphysiol.2013.260521] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 7.7] [Reference Citation Analysis]
81 Shi J, Gu P, Zhu Z, Liu J, Chen Z, Sun X, Chen W, Gao X, Zhang Z. Protein phosphatase 2A effectively modulates basal L-type Ca2+ current by dephosphorylating Cav1.2 at serine 1866 in mouse cardiac myocytes. Biochemical and Biophysical Research Communications 2012;418:792-8. [DOI: 10.1016/j.bbrc.2012.01.105] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
82 Nattel S, Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Am Coll Cardiol. 2014;63:2335-2345. [PMID: 24613319 DOI: 10.1016/j.jacc.2014.02.555] [Cited by in Crossref: 322] [Cited by in F6Publishing: 294] [Article Influence: 40.3] [Reference Citation Analysis]
83 Kirchhefer U, Brekle C, Eskandar J, Isensee G, Kučerová D, Müller FU, Pinet F, Schulte JS, Seidl MD, Boknik P. Cardiac function is regulated by B56α-mediated targeting of protein phosphatase 2A (PP2A) to contractile relevant substrates. J Biol Chem 2014;289:33862-73. [PMID: 25320082 DOI: 10.1074/jbc.M114.598938] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
84 Lei M, Wang X, Ke Y, Solaro RJ. Regulation of Ca(2+) transient by PP2A in normal and failing heart. Front Physiol 2015;6:13. [PMID: 25688213 DOI: 10.3389/fphys.2015.00013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
85 Biasucci LM, Cardillo MT. MicroRNA and Myocardial Infarction. Journal of the American College of Cardiology 2013;62:999-1001. [DOI: 10.1016/j.jacc.2013.03.084] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
86 Belevych AE, Ho HT, Bonilla IM, Terentyeva R, Schober KE, Terentyev D, Carnes CA, Györke S. The role of spatial organization of Ca2+ release sites in the generation of arrhythmogenic diastolic Ca2+ release in myocytes from failing hearts. Basic Res Cardiol 2017;112:44. [PMID: 28612155 DOI: 10.1007/s00395-017-0633-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
87 Lubbers ER, Mohler PJ. Roles and regulation of protein phosphatase 2A (PP2A) in the heart. J Mol Cell Cardiol 2016;101:127-33. [PMID: 27832939 DOI: 10.1016/j.yjmcc.2016.11.003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 6.5] [Reference Citation Analysis]
88 Siddeek B, Mauduit C, Yzydorczyk C, Benahmed M, Simeoni U. At the heart of programming: the role of micro-RNAs. J Dev Orig Health Dis 2018;9:615-31. [PMID: 29909803 DOI: 10.1017/S2040174418000387] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Chavali V, Tyagi SC, Mishra PK. Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/- Akita hearts. Cell Biochem Biophys. 2014;68:25-35. [PMID: 23797610 DOI: 10.1007/s12013-013-9679-4] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 7.4] [Reference Citation Analysis]
90 Little SC, Curran J, Makara MA, Kline CF, Ho HT, Xu Z, Wu X, Polina I, Musa H, Meadows AM, Carnes CA, Biesiadecki BJ, Davis JP, Weisleder N, Györke S, Wehrens XH, Hund TJ, Mohler PJ. Protein phosphatase 2A regulatory subunit B56α limits phosphatase activity in the heart. Sci Signal 2015;8:ra72. [PMID: 26198358 DOI: 10.1126/scisignal.aaa5876] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
91 Yang M, Wang L. MALAT1 knockdown protects from bronchial/tracheal smooth muscle cell injury via regulation of microRNA-133a/ryanodine receptor 2 axis. J Biosci 2021;46. [DOI: 10.1007/s12038-021-00149-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Andrés MD. Therapeutic potential for miR-133a/b to prevent Zinc Finger Homeobox 3 loss of function-dependent Atrial Fibrillation. Acta Physiol (Oxf) 2019;227:e13372. [PMID: 31465613 DOI: 10.1111/apha.13372] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
93 D’Alessandra Y, Pompilio G, Capogrossi MC. MicroRNAs and myocardial infarction. Curr Opin Cardiol. 2012;27:228-235. [PMID: 22476028 DOI: 10.1097/hco.0b013e3283522052] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
94 DeGrande ST, Little SC, Nixon DJ, Wright P, Snyder J, Dun W, Murphy N, Kilic A, Higgins R, Binkley PF, Boyden PA, Carnes CA, Anderson ME, Hund TJ, Mohler PJ. Molecular mechanisms underlying cardiac protein phosphatase 2A regulation in heart. J Biol Chem 2013;288:1032-46. [PMID: 23204520 DOI: 10.1074/jbc.M112.426957] [Cited by in Crossref: 61] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
95 Abdellatif M. Differential expression of microRNAs in different disease states. Circ Res. 2012;110:638-650. [PMID: 22343558 DOI: 10.1161/CIRCRESAHA.111.247437] [Cited by in Crossref: 102] [Cited by in F6Publishing: 57] [Article Influence: 10.2] [Reference Citation Analysis]
96 Sergienko NM, Donner DG, Delbridge LMD, McMullen JR, Weeks KL. Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities. Cell Signal 2021;91:110213. [PMID: 34902541 DOI: 10.1016/j.cellsig.2021.110213] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
97 Ohanian M, Humphreys DT, Anderson E, Preiss T, Fatkin D. A heterozygous variant in the human cardiac miR-133 gene, MIR133A2, alters miRNA duplex processing and strand abundance. BMC Genet 2013;14:18. [PMID: 23497314 DOI: 10.1186/1471-2156-14-18] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
98 Melman YF, Shah R, Das S. MicroRNAs in heart failure: is the picture becoming less miRky? Circ Heart Fail 2014;7:203-14. [PMID: 24449811 DOI: 10.1161/CIRCHEARTFAILURE.113.000266] [Cited by in Crossref: 56] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
99 Rawal S, Manning P, Katare R. Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease. Cardiovasc Diabetol. 2014;13:44. [PMID: 24528626 DOI: 10.1186/1475-2840-13-44] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 8.4] [Reference Citation Analysis]
100 Heijman J, Ghezelbash S, Wehrens XH, Dobrev D. Serine/Threonine Phosphatases in Atrial Fibrillation. J Mol Cell Cardiol 2017;103:110-20. [PMID: 28077320 DOI: 10.1016/j.yjmcc.2016.12.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
101 Zima AV, Bovo E, Mazurek SR, Rochira JA, Li W, Terentyev D. Ca handling during excitation-contraction coupling in heart failure. Pflugers Arch 2014;466:1129-37. [PMID: 24515294 DOI: 10.1007/s00424-014-1469-3] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 8.1] [Reference Citation Analysis]
102 Stølen TO, Høydal MA, Ahmed MS, Jørgensen K, Garten K, Hortigon-Vinagre MP, Zamora V, Scrimgeour NR, Berre AMO, Nes BM, Skogvoll E, Johnsen AB, Moreira JBN, McMullen JR, Attramadal H, Smith GL, Ellingsen Ø, Wisløff U. Exercise training reveals micro-RNAs associated with improved cardiac function and electrophysiology in rats with heart failure after myocardial infarction. J Mol Cell Cardiol 2020;148:106-19. [PMID: 32918915 DOI: 10.1016/j.yjmcc.2020.08.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
103 Masè M, Grasso M, Avogaro L, Nicolussi Giacomaz M, D'Amato E, Tessarolo F, Graffigna A, Denti MA, Ravelli F. Upregulation of miR-133b and miR-328 in Patients With Atrial Dilatation: Implications for Stretch-Induced Atrial Fibrillation. Front Physiol 2019;10:1133. [PMID: 31551809 DOI: 10.3389/fphys.2019.01133] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
104 Elzenaar I, Pinto YM, van Oort RJ. MicroRNAs in Heart Failure: New Targets in Disease Management. Clin Pharmacol Ther 2013;94:480-9. [DOI: 10.1038/clpt.2013.138] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
105 Henning RJ. Cardiovascular Exosomes and MicroRNAs in Cardiovascular Physiology and Pathophysiology. J Cardiovasc Transl Res 2021;14:195-212. [PMID: 32588374 DOI: 10.1007/s12265-020-10040-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
106 Potenza DM, Janicek R, Fernandez-Tenorio M, Niggli E. Activation of endogenous protein phosphatase 1 enhances the calcium sensitivity of the ryanodine receptor type 2 in murine ventricular cardiomyocytes. J Physiol 2020;598:1131-50. [PMID: 31943206 DOI: 10.1113/JP278951] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
107 Yang L, Lu X, Liu Y, Lv Z, Chen J, Yu W, Zhang Y, Nie Z. Expression analysis of miRNAs in BmN cells. Gene 2012;505:240-5. [PMID: 22713175 DOI: 10.1016/j.gene.2012.06.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
108 Kuz'min VS, Kobylina AA, Pustovit KB, Ivanova AD, Abramochkin DV. MicroRNA miR-133a-3p Facilitates Adrenergic Proarrhythmic Ectopy in Rat Pulmonary Vein Myocardium by Increasing cAMP Content. Bull Exp Biol Med 2022. [PMID: 35501645 DOI: 10.1007/s10517-022-05454-x] [Reference Citation Analysis]
109 Dobrev D, Wehrens XH. Role of RyR2 phosphorylation in heart failure and arrhythmias: Controversies around ryanodine receptor phosphorylation in cardiac disease. Circ Res 2014;114:1311-9; discussion 1319. [PMID: 24723656 DOI: 10.1161/CIRCRESAHA.114.300568] [Cited by in Crossref: 95] [Cited by in F6Publishing: 69] [Article Influence: 11.9] [Reference Citation Analysis]
110 Lozano-velasco E, Aranega A, Franco D. Non-Coding RNAs in the Cardiac Action Potential and Their Impact on Arrhythmogenic Cardiac Diseases. Hearts 2021;2:307-30. [DOI: 10.3390/hearts2030026] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Denniss AL, Dashwood AM, Molenaar P, Beard NA. Sarcoplasmic reticulum calcium mishandling: central tenet in heart failure? Biophys Rev 2020;12:865-78. [PMID: 32696300 DOI: 10.1007/s12551-020-00736-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
112 Wang Q, Hu W, Lei M, Wang Y, Yan B, Liu J, Zhang R, Jin Y. MiR-17-5p impairs trafficking of H-ERG K+ channel protein by targeting multiple er stress-related chaperones during chronic oxidative stress. PLoS One 2013;8:e84984. [PMID: 24386440 DOI: 10.1371/journal.pone.0084984] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]